GEN Exclusives

More »

GEN News Highlights

More »
Jan 16, 2014

Genetic Diagnostic Tests on the Horizon in Transgenomic Collab

  • Horizon Discovery and Transgenomic have entered into a collaboration to develop genetic diagnostic tests. The collaboration will enable Transgenomic to transition from the use of plasmid-derived controls to Horizon’s quantitative molecular reference standards for all of its existing assays and for any new assays developed in the future.

    As part of the agreement, Horizon will provide its renewable, genetically defined quantitative molecular reference standards in both genomic DNA and formalin fixed paraffin embedded format, through its Horizon Diagnostics division.

    The quantitative molecular reference standards will be used for Transgenomic’s range of genetic diagnostic tests, and in the development of new tests and in vitro diagnostic testing kits. The reference standard products will be chosen from Horizon Diagnostics’ existing inventory of more than 300 products, and Horizon’s GENESIS™ gene editing platform will also be employed to engineer new lines as needed.

    According to Horizon Diagnostics, its reference standard product portfolio comprises highly validated, engineered cell line derived material, including purified DNA with matched normal and renewable formalin fixed, paraffin embedded samples. The available specimens cover a range of oncology biomarkers, manufactured to standards including defined allelic frequencies.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »